Drug
sparsentan
Marketed as FILSPARI.
Generic name
sparsentan
Brand names
FILSPARI
First FDA approval
2023-02-17
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA216403 | FILSPARI | 2023-02-17 | TRAVERE |
Manufacturers
TRAVERE
Frequently asked questions
When was sparsentan FDA approved?
Earliest FDA approval on record: 2023-02-17.
What brand names are sold as sparsentan?
FILSPARI.
Sources
Appeal a sparsentan denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com